David E I Pyott
CIK 1051578 · Chairman of the Board and CEO · last filed 2026-11-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HENRI A. TERMEER SQUARE
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALNY | Director | 33,262 | $147.82 | $4.92M | -$9.50M | 19 | 2026-11-12 |
| TARS | Director | 10,958 | $77.67 | $851.1K | $0 | 4 | 2026-09-17 |
| PLRX | Director | — | $0.62 | — | $0 | 7 | 2025-06-09 |
| BMRN | Director | 49,750 | $61.42 | $3.06M | $1.00M | 11 | 2024-05-23 |
| AVY | Director | 18,684 | $183.14 | $3.42M | -$1.33M | 50 | 2020-04-24 |
| ALLERGAN INC (AGN) Delisted | Chairman of the Board and CEO | 399,832 | — | — | -$250.59M | 25 | 2015-02-24 |
| EW | Director | 307,440 | $103.88 | $31.94M | -$7.10M | 13 | 2013-05-17 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| ALNY | Direct | 5,362 | 16.1% | 2026-11-12 |
| by Trust | 27,900 | 83.9% | 2026-11-12 | |
| Total | 33,262 | |||
| TARS | Direct | 1,383 | 12.6% | 2026-04-28 |
| By the David E.I. Pyott Trust | 9,575 | 87.4% | 2026-09-17 | |
| Total | 10,958 | |||
| AGN | Direct | 165,659 | 41.4% | 2015-02-24 |
| By Living Trust | 229,096 | 57.3% | 2015-02-24 | |
| By Esop Trust | 2,896 | 0.7% | 2015-02-24 | |
| By 401(k) Trust | 2,180 | 0.5% | 2015-02-24 | |
| Total | 399,832 |
10b5-1 Trading Plans
3 plans| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| ALNY member of our board of directors |
Nov 12, 2025 | Feb 16, 2026 | Oct 14, 2026 | 7,610 shares | 3,830 (50%) last filed Jun 3, 2026 |
Ended | 10-K |
| ALNY Director |
Sep 5, 2024 | Dec 4, 2024 | Dec 17, 2025 | 7,440 shares | 7,440 (100%) last filed Mar 25, 2025 |
Ended | 10-Q |
| ALNY Director |
Aug 11, 2023 | Nov 9, 2023 | Aug 10, 2024 | 32,450 shares | 32,450 (100%) last filed Jun 26, 2024 |
Ended | 10-Q |
Recent Filings · Page 11 of 14
133 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-07-01 | AVY | Grant (A) | — | $0 | EDGAR |
| 2010-05-18 | EW | Grant (A) | +1,987 | $0 | EDGAR |
| 2010-04-26 | AVY | Grant (A) | — | $0 | EDGAR |
| 2010-04-01 | AVY | Grant (A) | — | $0 | EDGAR |
| 2010-03-04 | ALLERGAN INC (AGN) Delisted | Gift (G) | — | $0 | EDGAR |
| 2010-02-24 | ALLERGAN INC (AGN) Delisted | Mixed | +743 | -$38.5K | EDGAR |
| 2010-02-22 | EW | Mixed | — | -$971.6K | EDGAR |
| 2009-12-17 | AVY | Grant (A) | — | $0 | EDGAR |
| 2009-10-01 | AVY | Grant (A) | — | $0 | EDGAR |
| 2009-07-01 | AVY | Grant (A) | +750 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).